Aytu Biopharma (AYTU) Operating Income (2010 - 2026)
Aytu Biopharma (AYTU) posted quarterly Operating Income of -$4.1 million for Q1 2026, down 267.86% year-over-year from $2.4 million in Q1 2025, and down 106.29% quarter-over-quarter from -$2.0 million in Q4 2025.
Aytu Biopharma (AYTU) Operating Income (2010 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Operating Income for 17 consecutive years, with -$4.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Income fell 267.86% year-over-year to -$4.1 million; the TTM figure through Mar 2026 stood at -$15.2 million (down 512.07% YoY), while the FY2025 annual figure was -$7.8 million, down 391.95% from the prior year.
- Operating Income declined to -$4.1 million in Q1 2026 per AYTU's latest filing, from -$2.0 million in the prior quarter.
- Across five years, Operating Income topped out at $3.1 million in Q4 2023 and bottomed at -$53.4 million in Q1 2022.
- Historically, Operating Income has averaged -$6.1 million across 5 years, with a median of -$1.8 million in 2022.
- Annual changes were most pronounced in 2024 — Operating Income sank 1444.97% — and 2025, when it soared 251.6%.
- Aytu Biopharma's Operating Income stood at -$6.9 million in 2022, then surged by 145.81% to $3.1 million in 2023, then sank by 153.88% to -$1.7 million in 2024, then fell by 16.22% to -$2.0 million in 2025, then sank by 106.29% to -$4.1 million in 2026.
- Business Quant data shows AYTU's Operating Income at -$4.1 million in Q1 2026, -$2.0 million in Q4 2025, and -$1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Aytu Biopharma | 24.86 Mn | -1.86 Mn | 7.60 Mn | -4.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.06 Mn |
| Dec 31, 2025 | -1.97 Mn |
| Sep 30, 2025 | -1.50 Mn |
| Jun 30, 2025 | -7.62 Mn |
| Mar 31, 2025 | 2.42 Mn |
| Dec 31, 2024 | -1.70 Mn |
| Sep 30, 2024 | -930,000.00 |
| Jun 30, 2024 | -2.27 Mn |
| Mar 31, 2024 | -1.60 Mn |
| Dec 31, 2023 | 3.15 Mn |
| Sep 30, 2023 | -867,000.00 |
| Jun 30, 2023 | 169,000.00 |
| Mar 31, 2023 | -8.56 Mn |
| Dec 31, 2022 | -6.87 Mn |
| Sep 30, 2022 | -1.81 Mn |
| Jun 30, 2022 | -16.94 Mn |
| Mar 31, 2022 | -53.42 Mn |
| Dec 31, 2021 | -11.29 Mn |
| Sep 30, 2021 | -27.70 Mn |
| Jun 30, 2021 | -24.07 Mn |